Get started
Author

Dingrui Nie

BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
2022 · Mengjun Zhong, Rili Gao, et al. · Cell Death and Disease · 65
PDF
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Xin Liu, Shuxin Zhong, et al. · Experimental Hematology and Oncology · 63
PDF
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis
2022 · Dingrui Nie, Cunte Chen, et al. · Blood Science · 46
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
2024 · Chengwu Zeng, Dingrui Nie, et al. · Molecular Cancer · 41
Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin–proteasome pathway
2022 · Cunte Chen, Dingrui Nie, et al. · Journal of Leukocyte Biology · 34
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia
2023 · Xibao Yu, Cunte Chen, et al. · Cancer Medicine · 18
PDF
Vesicular formation regulated by ERK/MAPK pathway mediates human erythroblast enucleation
2021 · Chao An, Yumin Huang, et al. · Blood Advances · 17
CASP1 is a target for combination therapy in pancreatic cancer
2023 · Xianfeng Wang, Zheng Chen, et al. · European Journal of Pharmacology · 13
Aptamer sgc8-Modified PAMAM Nanoparticles for Targeted siRNA Delivery to Inhibit BCL11B in T-Cell Acute Lymphoblastic Leukemia
2024 · Xiangbo Zeng, Dingrui Nie, et al. · International Journal of Nanomedicine · 11
PDF
Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation
2023 · Xibao Yu, Xin Liu, et al. · European Journal of Pharmacology · 9
MiR-204 suppresses the progression of acute myeloid leukemia through HGF/c-Met pathway
2021 · Dingrui Nie, Ping Ma, et al. · Hematology · 7
Synergistic effects of BET inhibitors and ferroptosis inducers via targeted inhibition of the BRD4/c-Myc/NRF2 pathway in AML
2025 · Mengjun Zhong, Shuxin Zhong, et al. · European Journal of Pharmacology · 6
Targeting HSPA8 to repress GPX4 and induce ferroptosis in BCR-ABL positive leukemia
2025 · Shuxin Zhong, Dingrui Nie, et al. · Biomedical Technology · 4
Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
2022 · Mengjun Zhong, Rili Gao, et al. · Cell Death and Disease · 2
PDF
3109 – Synergistic Treatment of T-cell Acute Lymphoblastic Leukemia With Bortezomib Combined With Daunorubicin
2025 · Yangqiu Li, Xiangbo Zeng, et al. · Experimental Hematology
Additional file 4 of Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Liu, Xin, Zhong, Shuxin, et al. · Figshare
Additional file 3 of Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Liu, Xin, Zhong, Shuxin, et al. · Figshare
Additional file 2 of Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Liu, Xin, Zhong, Shuxin, et al. · Figshare
MiR-204 suppresses the progression of acute myeloid leukemia through HGF/c-Met pathway
2021 · Nie, Dingrui, Ma, Ping, et al. · Figshare
Works count: 22
Citation count: 335
H-index: 9
I10-index: 9
Year
Topic
Type